KDM6A and cancer: The HPV-mediated subversion of the tumor suppressive activities of KDM6A and KDM6B and the ensuing addiction to these two enzymes of high-risk HPV expressing cells, but not normal cells, is not only of academic interest, but also provides novel therapeutic targets for high-risk HPV-associated lesions and cancers.